Monitor for any unexpected CFO transition risks during the handover period, though the orderly transition and retention of Mackaness as consultant mitigate immediate concerns. Watch for changes in financial guidance or capital allocation strategy under new leadership.
Price Chart
Executive Summary
Soleno Therapeutics announced the retirement of CFO James Mackaness and the appointment of Jennifer Fulk as incoming CFO, effective March 2, 2026. Fulk will receive a $525,000 base salary and equity awards totaling 106,860 shares. Mackaness will transition to a consulting role through year-end.
Key Facts
- Jennifer Fulk appointed CFO effective March 2, 2026
- James Mackaness retiring, will serve as consultant through December 31, 2026
- Fulk's compensation: $525,000 base salary, 67,660 stock options, 39,200 RSUs
- Fulk previously CFO at Talkspace and held executive roles at Eli Lilly
- No disagreement cited in Mackaness's departure
Financial Impact
Approximately $525,000 annual cash compensation plus equity awards valued at approximately $1.4 million at current stock price (based on 106,860 shares)
Risk Factors
- Potential disruption during CFO transition
- Increased compensation expenses
- Equity dilution from new grants
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-073209 |
| Document: d110816dex101.htm | 0001193125-26-073209 |
| Document: d110816dex991.htm | 0001193125-26-073209 |
| Document: 0001193125-26-073209-index-headers.html | 0001193125-26-073209 |
| Document: 0001193125-26-073209-index.html | 0001193125-26-073209 |
| Document: 0001193125-26-073209.txt | 0001193125-26-073209 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 11, 2026 16w ago | Institutional Cluster | — | awaiting T+1 | — | — |
Jun 11, 2026 16w ago | Institutional Cluster | — | awaiting T+1 | — | — |
May 28, 2026 18w ago | 15-12G | — | awaiting T+1 | — | — |
May 28, 2026 18w ago | EFFECT | — | awaiting T+1 | — | — |
May 18, 2026 19w ago | 8-K / 25-NSE | $53.01 $53.01 | · 0.00% | ▲ +0.65% | — |
Apr 7, 2026 25w ago | 8-K | $52.35 $52.60 | ▼ −0.48% | ▲ +2.06% | — |
Apr 6, 2026 25w ago | 8-K | $52.25 $52.35 | ▲ +0.19% | ▲ +0.13% | — |
Mar 27, 2026 27w ago | Insider Cluster | $30.05 $30.44 | ▲ +1.30% | ▲ +1.66% | — |
Feb 26, 2026 31w ago | 8-K | $38.09 $39.07 | ▲ +2.57% | ▲ +3.03% | — |
Feb 25, 2026 31w ago | 8-K | $41.01 $38.09 | ▼ −7.12% | ▼ −6.57% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access